Eye-Opening study: could a simple supplement protect your retina?
NCT ID NCT07314411
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether taking a daily carotenoid supplement for 3 months can improve retinal health in healthy adults aged 18-75. Researchers will measure changes in macular pigment, retinal thickness, blood flow, and vision, as well as cognitive function. Participants are randomly assigned to receive either the supplement or a placebo. The goal is to understand if these nutrients can help protect the retina and reduce waste buildup.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- carotenoid supplement (dietary supplement)
- What this could lead to
- If it works, this could show that a simple daily supplement helps protect the retina and may reduce the risk of age-related vision problems.
- What could go wrong
- This is a small, early-stage trial in healthy people, so results may not apply to those with eye disease. The supplement may show no benefit over placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pacific University
RECRUITINGForest Grove, Oregon, 97116, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test